The intellectual exchange between human genetics and biomedical science has produced some of the most important and fruitful scientific discoveries of the past 50 years. The advances in human genetics and genomics made possible by the Human Genome Project and its aftermath have revolutionized the way scientific investigation is carried out in the areas of human disease and its animal models. In addition, the elucidation of the genetic contribution to literally thousands of human diseases has provided innumerable fundamental insights into normal biological function.
Many laboratories at UCSF use genetic approaches to untangle problems as diverse as infertility, cancer, adverse drug reactions, asthma, autism, birth defects, neurological diseases, obesity, diabetes and many others. Our faculty are leaders in the development of cutting-edge genome technologies including microarrays, comparative genome hybridization (CGH), whole-genome sequencing, population genetics, genetic epidemiology and computational genomics. They also use model organisms to discover and explore fundamental pathways that can lead to human disease.
All entering BMS Students take a core Genetics course (BMS 255) and can opt to take a seminar course BMS270 entitled “Disease Discovery through the Lens of Genetics” offered every other spring. Through the UCSF Institute for Human Genetics (http://humgen.medschool.ucsf.edu/), students can interact with numerous genetic-oriented faculty and attend monthly genetic and genomic technology seminars. The faculty in Genetics participate broadly in the Graduate Education in Medical Science (GEMS) Training Program in which students can choose to focus on research problems direclty relevant to human health. (http://physio.ucsf.edu/GEMS/index.asp).
Participating Faculty
Primary Research Interest: ImmunologySecondary Research Interest: Human GeneticsThe Genetic Control of Autoimmune Disease
Primary Research Interest: Human GeneticsPharmacogenomics and Genetic Epidemiology of Pulmonary Diseases
Primary Research Interest: Human GeneticsProteasomes, substrate recognition and processing
Primary Research Interest: Human GeneticsSecondary Research Interest: ImmunologyGenetics and epidemiology of human autoimmune disease
Primary Research Interest: Human GeneticsGenomic approaches to yeast molecular biology and infectious disease
Primary Research Interest: Human GeneticsSecondary Research Interest: NeurobiologyHuman genetics in neurodegenerative disease and circadian/sleep behavior
Control of Gene Expression
Primary Research Interest: Human GeneticsAnalysis of Complex Genetic Traits
Primary Research Interest: Human GeneticsSecondary Research Interest: NeurobiologyGenetic Analysis of Parkinson's disease and other disorders
Primary Research Interest: Human GeneticsSecondary Research Interest: NeurobiologyGenetics and biology of human nervous system disorders
Primary Research Interest: ImmunologySecondary Research Interest: Human GeneticsInherited disorders of lymphocyte development
Primary Research Interest: Human GeneticsHuman Genetics, Population Genetics, Statistical Genetics, Genetic Epidemiology
Primary Research Interest: Human GeneticsSecondary Research Interest: ImmunologyPopulation Genetics and Human Genetics of Host Defense, Autoimmune Disease, and Diabetes
Primary Research Interest: Human GeneticsSecondary Research Interest: NeurobiologyThe genetics of autism and epilepsy: studies in cerebral development and connectivity
Primary Research Interest: Cancer Biology & Cell SignalingSecondary Research Interest: Human GeneticsDr. van ‘t Veer is a world renowned Molecular Pathologist, former Head of Diagnostic Oncology at the Netherlands Cancer Institute, and inventor of MammaPrint. She is the P.I. of the Bay Area Breast SPORE and Leader of the Breast Oncology Program in the Helen Diller Family Comprehensive Cancer Center. Dr. van ‘t Veer’s research focuses on Personalized Medicine, to advance that patient management is based on knowledge of the genetic make-up of the tumor as well as the genetic make-up of the patient. This allows to optimally assign systemic therapy for those patients that are in need of such treatment and to ensure the selection of the therapy that is most effective. Dr. van ‘t Veer’s research shows that molecular diagnostics and microarray genomics technology increasingly impacts patient management. Molecular Genomics contributes to the knowledge of who is at risk for breast cancer, how external factors may influence this risk, whether breast tumors are likely to metastasize or not, and which subtype of tumors will likely respond to what therapy.
Primary Research Interest: Human GeneticsEvolutionary and Human Genetics
Primary Research Interest: Human GeneticsSecondary Research Interest: ImmunologyDevelopment of statistical methods for uncovering the genetic basis of human disease
Primary Research Interest: Human GeneticsApplication of Population Genetics to the Study of Complex Traits in Humans